Home/Filings/4/0001213900-22-027983
4//SEC Filing

Kaplan Myron 4

Accession 0001213900-22-027983

CIK 0001410098other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 5:21 PM ET

Size

16.3 KB

Accession

0001213900-22-027983

Insider Transaction Report

Form 4
Period: 2022-05-17
Kaplan Myron
Director
Transactions
  • Purchase

    Common Stock

    2022-05-17$3.78/sh+5,000$18,900160,034 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    20,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $8.32Exp: 2031-01-11Common Stock (30,000 underlying)
    30,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $5.63Exp: 2030-02-25Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $8.30Exp: 2029-01-10Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to(Right to Buy Common Stock)

    Exercise: $2.85Exp: 2028-02-16Common Stock (8,000 underlying)
    8,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $21.40Exp: 2026-04-28Common Stock (10,000 underlying)
    1,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $4.03Exp: 2032-02-22Common Stock (20,000 underlying)
    20,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $11.20Exp: 2027-02-21Common Stock (8,000 underlying)
    8,000
  • Common Stock

    (indirect: By Spouse)
    10,000
Footnotes (9)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.77 to $3.79, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  • [F3]These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
  • [F4]These options were granted on 1/11/2021. These options are fully vested.
  • [F5]These options were granted on 2/25/2020. These options are fully vested.
  • [F6]These options were granted on 1/10/2019. These options are fully vested.
  • [F7]These options were granted on 2/16/2018. These options are fully vested.
  • [F8]These options were granted on 2/21/2017. These options are fully vested.
  • [F9]These options were granted on 4/28/2016. These options are fully vested.

Documents

1 file

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1
  • filerCIK 0001672645

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 5:21 PM ET
Size
16.3 KB